Climedo brings late-phase and post-approval studies, from non-interventional and registry studies to direct-to-patient studies and surveys, onto one EU-hosted eCOA and EDC platform. Autonomous Data Capture (ADC) takes data from source documents, patients and sites with near-zero manual entry, so efficacy and safety evidence is visible while the study is still running.
In most real-world and late-phase studies, data still travels from patient to database by hand: transcribed from paper, PDFs, portals and clinical records. That manual step is where time, data quality and speed to insight are lost, inside post-approval windows that are short to begin with.
Patient satisfaction and quality-of-life surveys, HCP feedback and market research, on any device, in several languages.
eCOA and ePRO, remote monitoring and decentralized designs, with automated reminders and no app to install.
Post-approval, observational, implementation and registry studies with full EDC, source data verification and site management.
Autonomous Data Capture moves study data into the EDC in three stages, with a human in the loop.
Source data comes in without manual entry.
AI structures unstructured data.
Human-approved import, with the groundwork done by AI.
Follow recruitment, compliance and selected parameters across visits, benchmark sites and spot outliers early. Descriptive while the study runs, never a prescribing aid.
The AI Study Configurator turns your protocol into a ready study, from eCRFs, visits, randomization and ePRO to edit checks and SAE forms, so a study goes from protocol upload to live in 3 to 5 days instead of 2 to 3 weeks.
Real-world evidence (RWE) is clinical evidence about the use, benefits and risks of a treatment, drawn from real-world data such as health records, patient-reported outcomes and registries, rather than only from randomized controlled trials.
Patient surveys, direct-to-patient studies with eCOA and ePRO, and non-interventional studies such as post-approval, observational, implementation and registry studies.
Through EHR and HIS integration where it exists, and otherwise through photo capture: sites photograph or screenshot a record, AI extracts the eCRF fields and the site reviews them before saving.
All servers are in Frankfurt (AWS region); for EU studies, no data is processed outside the EU, and US hosting (HIPAA) is possible on request. AI processing runs in private, EU-hosted model instances, and your data is never used to train public models.
Phase I to IV, interventional and non-interventional, with a focus on late-phase and post-approval studies.
Yes. CROs run their studies on one platform, with reusable templates and workflows, granular roles and rights, and data exports in common formats.